The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,799.50
Bid: 1,796.00
Ask: 1,796.50
Change: 19.00 (1.07%)
Spread: 0.50 (0.028%)
Open: 1,784.00
High: 1,799.50
Low: 1,780.00
Prev. Close: 1,780.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: On The Beach adds Justine Greening to board

Fri, 05th Mar 2021 15:10

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and Friday and not separately reported by Alliance News:

----------

On The Beach Group PLC - Manchester-based online retailer of beach holidays - Hires former UK government minister Justine Greening as non-executive director, effective immediately. Greening served as transport secretary between 2011 and 2012 and as education secretary from 2016 to 2018 before leaving government that year. Before her political career, during which she represented Putney in west London, Greening was an accountant with PriceWaterhouse and held a strategy role at GlaxoSmithKline PLC. "It is a privilege that Justine has chosen On the Beach as her first corporate non-executive director role, and we look forward to working with her and benefiting from her extensive knowledge and expertise," says Chair Richard Pennycook. "As the travel sector recovers from the pandemic, we expect some fairly major reforms to the regulatory landscape. Justine's experience, in and out of Westminster, will be invaluable as On the Beach navigates these reforms and pursues opportunities to grow our market share both in the UK and internationally."

----------

K3 Business Technology Group PLC - Manchester-based enterprise software firm - Adalsteinn Valdimarsson steps down as chief executive officer, effective immediately. Chair Tom Crawford will be interim CEO while a replacement is found. K3 says departure follows the disposal of Starcom Technologies Ltd, which strengthened the company's financial position and allowed it to move onto a new phase of development. K3 sold Starcom last month to infrastructure and services company Node4 Ltd for GBP14.7 million in cash. Will provide an update on the recruitment process at its annual results on March 30.

----------

Andrews Sykes Group PLC - Wolverhampton-based heating and cooling rental company - Confirms Carl Webb as managing director. Webb was made interim MD in January, having been MD of the UK business for 15 years. Webb replaces Paul Wood, who died at the end of January.

----------

Sabien Technology Group PLC - Maidenhead, England-based energy efficiency technology - Promotes Edward Sutcliffe to chief financial office and board director, effective immediately. Sutcliffe has been interim finance director and company secretary since June 2017.

----------

IG Group Holdings PLC - London-based contracts-for-difference trading platform - Hire Lisa Pollina as non-executive director, starting immediately. Pollina is on the board of insurer Munich RE AG, representing the Americas. She also was vice chair of RBC Capital Markets, part of Royal Bank of Canada.

----------

Surface Transforms PLC - Liverpool-based maker of automotive brake discs - Matthew Taylor and Julia Woodhouse added to board as non-executive directors, both effective immediately. Taylor retired last year as CEO of Bekaert SA, a Belgium-based steel wire business. Woodhouse retired from Ford Motor Co in 2018, having served as director of Global Power Train Purchasing, based in the US, and director of Global Chassis Purchasing, based in Germany.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.